Haemonetics Corp
(STU:HAZ)
€
65.5
(0%)
Market Cap: 2.99 Bil
Enterprise Value: 3.85 Bil
PE Ratio: 37.13
PB Ratio: 4.26
GF Score: 84/100 Haemonetics Corp at Goldman Sachs Healthcare Conference Transcript
Jun 08, 2026 / 08:00PM GMT
Release Date Price:
€65
(+5.69%)
Unidentified Participant
Good afternoon, everyone. Pleased to welcome you to (inaudible) -- our last session of day 1 of the conference.
Very pleased to welcome Chris Simon, President and CEO of Haemonetics. Thank you, again, for making the trip to Miami.
We were catching up before this. It's been a long time (multiple speakers) --
Christopher Simon
Haemonetics Corp - President, Chief Executive Officer, Director
Long time.
Unidentified Participant
-- since I saw you. You were here last year. But, obviously, we go back much farther than that in terms of the evolution of the company.
Questions & Answers
Unidentified Participant
Maybe just -- you've completed an LRP. You've just set out fiscal year guidance. Talk to us -- like, where are you in this transformation of Haemonetics?
Christopher Simon
Haemonetics Corp - President, Chief Executive Officer, Director
Thanks. Thanks for having us at the conference. Delighted to be
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot